Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.

× No keyword cloud information.

32 in total

1. Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involved axillary nodes.

Authors: P Fumoleau; F Chauvin; M Namer; R Bugat; M Tubiana-Hulin; J P Guastalla; T Delozier; P Kerbrat; Y Devaux; J Bonneterre; A Filleul; M Clavel
Journal: J Clin Oncol Date: 2001-02-01 Impact factor: 44.544

2. Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes.

Authors: Arnold L Potosky; Jennifer L Malin; Benjamin Kim; Elizabeth A Chrischilles; Solomon B Makgoeng; Nadia Howlader; Jane C Weeks
Journal: J Natl Cancer Inst Date: 2011-06-13 Impact factor: 13.506

3. Lenograstim as support for ACE chemotherapy of small-cell lung cancer: a phase III, multicenter, randomized study.

Authors: U Gatzemeier; J P Kleisbauer; P Drings; E Kaukel; N Samaras; M J Melo; F Cardenal; G Robinet; R J Snijder; J von Pawel; R Palisses
Journal: Am J Clin Oncol Date: 2000-08 Impact factor: 2.339

4. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.

Authors: J Crawford; H Ozer; R Stoller; D Johnson; G Lyman; I Tabbara; M Kris; J Grous; V Picozzi; G Rausch
Journal: N Engl J Med Date: 1991-07-18 Impact factor: 91.245

5. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.

Authors: J K Doorduijn; B van der Holt; G W van Imhoff; K G van der Hem; M H H Kramer; M H J van Oers; G J Ossenkoppele; M R Schaafsma; L F Verdonck; G E G Verhoef; M M C Steijaert; I Buijt; C A Uyl-de Groot; M van Agthoven; A H Mulder; P Sonneveld
Journal: J Clin Oncol Date: 2003-08-15 Impact factor: 44.544

6. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial.

Authors: R Pettengell; H Gurney; J A Radford; D P Deakin; R James; P M Wilkinson; K Kane; J Bentley; D Crowther
Journal: Blood Date: 1992-09-15 Impact factor: 22.113

7. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy.

Authors: V Trillet-Lenoir; J Green; C Manegold; J Von Pawel; U Gatzemeier; B Lebeau; A Depierre; P Johnson; G Decoster; D Tomita
Journal: Eur J Cancer Date: 1993 Impact factor: 9.162

8. Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas.

Authors: H H Gerhartz; M Engelhard; P Meusers; G Brittinger; W Wilmanns; G Schlimok; P Mueller; D Huhn; R Musch; W Siegert
Journal: Blood Date: 1993-10-15 Impact factor: 22.113

9. Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.

Authors: M Engelhard; H Gerhartz; G Brittinger; A Engert; R Fuchs; B Geiseler; D Gerhartz; A R Haunauske; H J Hartlapp; D Huhn
Journal: Ann Oncol Date: 1994 Impact factor: 32.976

10. Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.

Authors: P J Woll; J Hodgetts; L Lomax; F Bildet; V Cour-Chabernaud; N Thatcher
Journal: J Clin Oncol Date: 1995-03 Impact factor: 44.544